» Articles » PMID: 38731977

Exosomes Secreted by Wharton's Jelly-Derived Mesenchymal Stem Cells Promote the Ability of Cell Proliferation and Migration for Keratinocyte

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 May 11
PMID 38731977
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) isolated from Wharton's jelly (WJ-MSCs) and adipose tissue (AD-MSCs) are alternative sources for bone marrow-derived MSCs. Owing to their multiple functions in angiogenesis, immune modulation, proliferation, migration, and nerve regeneration, MSC-derived exosomes can be applied in "cell-free cell therapy". Here, we investigated the functional protein components between the exosomes from WJ-MSCs and AD-MSCs to explain their distinct functions. Proteins of WJ-MSC and AD-MSC exosomes were collected and compared based on iTRAQ gel-free proteomics data. Results: In total, 1695 proteins were detected in exosomes. Of these, 315 were more abundant (>1.25-fold) in AD-MSC exosomes and 362 kept higher levels in WJ-MSC exosomes, including fibrinogen proteins. Pathway enrichment analysis suggested that WJ-MSC exosomes had higher potential for wound healing than AD-MSC exosomes. Therefore, we treated keratinocyte cells with exosomes and the recombinant protein of fibrinogen beta chain (FGB). It turned out that WJ-MSC exosomes better promoted keratinocyte growth and migration than AD-MSC exosomes. In addition, FGB treatment had similar results to WJ-MSC exosomes. The fact that WJ-MSC exosomes promoted keratinocyte growth and migration better than AD-MSC exosomes can be explained by their higher FGB abundance. Exploring the various components of AD-MSC and WJ-MSC exosomes can aid in their different clinical applications.

Citing Articles

Unraveling the Exosome-miR-133a Axis: Targeting TGF-β Signaling via WJ-MSC-Derived Exosomes for Anti-Fibrotic Therapy in Liver Fibrosis.

Saki S, Monjezi S, Ghaffari F, Orak G, Salehipour Bavarsad S, Khedri A Iran Biomed J. 2024; 28(5 & 6):235-44.

PMID: 39629623 PMC: 11829155. DOI: 10.61186/ibj.4357.

References
1.
Velnar T, Bailey T, Smrkolj V . The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009; 37(5):1528-42. DOI: 10.1177/147323000903700531. View

2.
Sastre B, Canas J, Rodrigo-Munoz J, Del Pozo V . Novel Modulators of Asthma and Allergy: Exosomes and MicroRNAs. Front Immunol. 2017; 8:826. PMC: 5519536. DOI: 10.3389/fimmu.2017.00826. View

3.
Zhao G, Liu F, Liu Z, Zuo K, Wang B, Zhang Y . MSC-derived exosomes attenuate cell death through suppressing AIF nucleus translocation and enhance cutaneous wound healing. Stem Cell Res Ther. 2020; 11(1):174. PMC: 7212595. DOI: 10.1186/s13287-020-01616-8. View

4.
Phinney D, Pittenger M . Concise Review: MSC-Derived Exosomes for Cell-Free Therapy. Stem Cells. 2017; 35(4):851-858. DOI: 10.1002/stem.2575. View

5.
Baharlooi H, Azimi M, Salehi Z, Izad M . Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Ace Card to Address Autoimmune Diseases. Int J Stem Cells. 2019; 13(1):13-23. PMC: 7119210. DOI: 10.15283/ijsc19108. View